The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| AFFY | +12.5% | -99.36% | -63.56% | -100% |
| S&P | +14.08% | +93.57% | +14.12% | +380% |
Affymax, Inc. is a biopharmaceutical company. It is engaged in the developing of nephrology and specialty care space by delivering innovative therapeutical offerings to patients and healthcare providers. The company was founded on July 20, 2001 and is headquartered in New York, NY.
The Nasdaq hasn't had a down month this year, but that's not stopping skeptics from piling onto these five companies.
There's more than one way to see monster drops.
No data available for this period.
Currently no data to display
Currently no data to display.
Currently no data to display.
No data available for this period.
No data available for this period.
No data available for this period.
No data available for this period.
| Metric | YoY Change |
|---|
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
